These findings highlight the dual role of SIRT7 in HCC: while it promotes cancer cell proliferation, survival, and migration through tumor-intrinsic oncogenic pathways, it simultaneously facilitates immune recognition by diminishing PD-L1-mediated immune evasion. Here, SIRT7 is linked to hepatocellular carcinoma.